Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & Unicycive Therapeutics

2 shared events · Importance 3 · Last updated Sep 22, 2026

Importance
3
Shared Events
2
Actions
5
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
89
Regulatory
United States — Food and Drug Administration: The FDA issued a second Complete Response Letter for Unicycive's OLC NDA, citing manufacturing deficiencies, which triggered the stock decline and investigation.
Unicycive Therapeutics: Unicycive Therapeutics is the subject of a securities investigation following a second FDA Complete Response Letter for its OLC NDA, causing a stock price decline.
Jun 30, 2026 · 13 articles
77
Regulatory
United States — Food and Drug Administration: The FDA issued the Complete Response Letter for Unicycive's resubmitted NDA for oxylanthanum carbonate, citing the same third-party manufacturing deficiencies as the prior June 2025 CRL, which triggered the stock decline and the lawsuits.
Unicycive Therapeutics: Unicycive is the defendant and central subject of the securities fraud class action, facing allegations of misleading investors about third-party manufacturing deficiencies and the resulting FDA Complete Response Letter for oxylanthanum carbonate. The stock reportedly fell 39.1% on the CRL disclosure, and the litigation adds legal costs and reputational damage.
Sep 03, 2026 · 58 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and Unicycive Therapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.